PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC: MDXXF), a biotechnology company focused on the research, development, and manufacturing of LaNeo™ MDMA and novel ...

This is the web version of STAT’s special newslette r from the annual meeting of the American Society of Oncology. For more ...

MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on discovering, developing, manufacturing and ...

Moderna announced Wednesday that the Trump administration has canceled a major contract worth nearly $700 million for the ...

CNW/ -- (CSE: BIOV) (FRA: 5LB) ("BioVaxys" or the "Company") is pleased to provide a summary of current operating ...

An colon cancer study highlighted the importance of the National Cancer Institute, while cancer doctors got a look at a ...

PharmAla Biotech (CSE:MDMA) issued a public warning after discovering that unknown parties are illegally marketing a nasal ...

The new SCIEX OS software version 4.0 is the latest evolution of its powerful software platform. This new Microsoft Windows 11 compatible release drives operability enhancements with speed and ...

PharmAla says its LaNeo MDMA drug products are exclusively available through a qualified practitioner’s prescription and ...